Harnessing autophagy: A potential breakthrough in digestive disease treatment
- PMID: 38983959
- PMCID: PMC11230060
- DOI: 10.3748/wjg.v30.i24.3036
Harnessing autophagy: A potential breakthrough in digestive disease treatment
Abstract
Autophagy, a conserved cellular degradation process, is crucial for various cellular processes such as immune responses, inflammation, metabolic and oxidative stress adaptation, cell proliferation, development, and tissue repair and remodeling. Dysregulation of autophagy is suspected in numerous diseases, including cancer, neurodegenerative diseases, digestive disorders, metabolic syndromes, and infectious and inflammatory diseases. If autophagy is disrupted, for example, this can have serious consequences and lead to chronic inflammation and tissue damage, as occurs in diseases such as Chron's disease and ulcerative colitis. On the other hand, the influence of autophagy on the development and progression of cancer is not clear. Autophagy can both suppress and promote the progression and metastasis of cancer at various stages. From inflammatory bowel diseases to gastrointestinal cancer, researchers are discovering the intricate role of autophagy in maintaining gut health and its potential as a therapeutic target. Researchers should carefully consider the nature and progression of diseases such as cancer when trying to determine whether inhibiting or stimulating autophagy is likely to be beneficial. Multidisciplinary approaches that combine cutting-edge research with clinical expertise are key to unlocking the full therapeutic potential of autophagy in digestive diseases.
Keywords: Autophagy; Digestive disease; Gastrointestinal cancer; Harnessing autophagy; Inflammatory bowel disease.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.Gastroenterology. 2012 Sep;143(3):550-563. doi: 10.1053/j.gastro.2012.07.009. Epub 2012 Jul 13. Gastroenterology. 2012. PMID: 22796521 Review.
-
[Features of bone metabolism in patients with chronic diseases of digestive system].Eksp Klin Gastroenterol. 2011;(9):80-6. Eksp Klin Gastroenterol. 2011. PMID: 22629781 Russian.
-
Effects of calcium‑permeable ion channels on various digestive diseases in the regulation of autophagy (Review).Mol Med Rep. 2021 Sep;24(3):680. doi: 10.3892/mmr.2021.12319. Epub 2021 Jul 28. Mol Med Rep. 2021. PMID: 34318907 Review.
-
SP and KLF Transcription Factors in Digestive Physiology and Diseases.Gastroenterology. 2017 Jun;152(8):1845-1875. doi: 10.1053/j.gastro.2017.03.035. Epub 2017 Mar 30. Gastroenterology. 2017. PMID: 28366734 Free PMC article. Review.
-
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.Int J Mol Sci. 2020 Nov 5;21(21):8308. doi: 10.3390/ijms21218308. Int J Mol Sci. 2020. PMID: 33167521 Free PMC article. Review.
Cited by
-
The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential.Front Immunol. 2024 Oct 31;15:1487576. doi: 10.3389/fimmu.2024.1487576. eCollection 2024. Front Immunol. 2024. PMID: 39544947 Free PMC article. Review.
References
-
- Eskelinen EL. Autophagy: Supporting cellular and organismal homeostasis by self-eating. Int J Biochem Cell Biol. 2019;111:1–10. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical